JTC provides tools and guidance to help editors manage thyroid cancer submissions efficiently.

Resources focus on standardized review workflows, ethical compliance, and reporting quality.

• Confirm scope fit and thyroid cancer relevance early
• Match reviewers to surgical, pathology, or molecular expertise
• Verify ethics approvals and consent documentation
• Request clarity on staging and treatment protocols
• Monitor review timelines and follow up promptly
• Encourage consistent decision letters and clear revision guidance.
• Ensure reviewer expertise matches thyroid cancer subtopics.
• Confirm ethics approvals and patient consent documentation.
• Monitor turnaround times and communicate delays promptly.
• Promote data transparency and reproducibility statements.
• Document conflicts of interest and recuse when needed.
• Coordinate with guest editors to align on scope fit.
• Verify clinical trial registration and reporting quality.
• Ensure statistical review for complex molecular studies.
• Request data access statements for sensitive clinical datasets.
• Encourage adherence to CONSORT, STROBE, PRISMA, or CARE.
• Check that imaging and pathology reporting are adequate.
• Ensure conclusions align with data and avoid overstatement.
• Promote clear reporting of surgical and systemic treatment details.
• Encourage reporting of staging criteria and risk stratification.
• Verify that surgical and adjuvant therapy details are complete.
• Request clarification on imaging criteria and response assessments.
• Promote inclusion of clinical practice implications in conclusions.

JTC is committed to rigorous, transparent publishing in thyroid cancer research and care. We emphasize reproducible clinical methods, clear reporting of diagnostic criteria, and ethical compliance across all article types.

The editorial office supports authors, editors, and reviewers with clear guidance and responsive communication. For questions about scope or workflow, contact [email protected].

We encourage continuous improvement in reporting practices and share updates that help the community maintain high standards in endocrine oncology, surgical outcomes, and translational thyroid research.